Cargando…

Capsid-specific removal of circulating antibodies to adeno-associated virus vectors

Neutralizing antibodies directed against adeno-associated virus (AAV) are commonly found in humans. In seropositive subjects, vector administration is not feasible as antibodies neutralize AAV vectors even at low titers. Consequently, a relatively large proportion of humans is excluded from enrollme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bertin, Berangere, Veron, Philippe, Leborgne, Christian, Deschamps, Jack-Yves, Moullec, Sophie, Fromes, Yves, Collaud, Fanny, Boutin, Sylvie, Latournerie, Virginie, van Wittenberghe, Laetitia, Delache, Benoit, Le Grand, Roger, Dereuddre-Bosquet, Nathalie, Benveniste, Olivier, Moullier, Philippe, Masurier, Carole, Merten, Otto, Mingozzi, Federico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972890/ https://www.ncbi.nlm.nih.gov/pubmed/31965041 http://dx.doi.org/10.1038/s41598-020-57893-z

Ejemplares similares

Determination of Anti-Adeno-Associated Virus Vector Neutralizing Antibody Titer with an In Vitro Reporter System
por: Meliani, Amine, et al.
Publicado: (2015)

Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction
por: Fitzpatrick, Zachary, et al.
Publicado: (2018)

Chemical modification of the adeno-associated virus capsid to improve gene delivery
por: Mével, Mathieu, et al.
Publicado: (2019)

A translationally optimized AAV-UGT1A1 vector drives safe and long-lasting correction of Crigler-Najjar syndrome
por: Ronzitti, Giuseppe, et al.
Publicado: (2016)

Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler–Najjar Syndrome
por: Aronson, Sem J., et al.
Publicado: (2019)

Highly efficient transduction of human plasmacytoid dendritic cells without phenotypic and functional maturation
por: Veron, Philippe, et al.
Publicado: (2009)

Origins of truncated supplementary capsid proteins in rAAV8 vectors produced with the baculovirus system
por: Galibert, Lionel, et al.
Publicado: (2018)

The Role of the Adeno-Associated Virus Capsid in Gene Transfer
por: Van Vliet, Kim M., et al.
Publicado: (2008)

Adeno-associated virus capsid assembly is divergent and stochastic
por: Wörner, Tobias P., et al.
Publicado: (2021)

Different protein composition and functional properties of adeno-associated virus-6 vector manufactured from the culture medium and cell lysates
por: Denard, Jerome, et al.
Publicado: (2014)

Adeno-associated virus capsid protein expression in Escherichia coli and chemically defined capsid assembly
por: Le, Dinh To, et al.
Publicado: (2019)

Post‐translational modifications in capsid proteins of recombinant adeno‐associated virus (AAV) 1‐rh10 serotypes
por: Mary, Bertin, et al.
Publicado: (2019)

AAV Gene Transfer with Tandem Promoter Design Prevents Anti-transgene Immunity and Provides Persistent Efficacy in Neonate Pompe Mice
por: Colella, Pasqualina, et al.
Publicado: (2018)

Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy
por: Le Guiner, Caroline, et al.
Publicado: (2017)

Adeno-Associated Viral Vectors at the Frontier between Tolerance and Immunity
por: Mingozzi, Federico, et al.
Publicado: (2015)

Transposon-mediated Generation of Cellular and Mouse Models of Splicing Mutations to Assess the Efficacy of snRNA-based Therapeutics
por: Barbon, Elena, et al.
Publicado: (2016)

Short-lived recombinant adeno-associated virus transgene expression in dystrophic muscle is associated with oxidative damage to transgene mRNA
por: Dupont, Jean-Baptiste, et al.
Publicado: (2015)

Improving clinical efficacy of adeno associated vectors by rational capsid bioengineering
por: Sen, Dwaipayan
Publicado: (2014)

Electrophoresis-Mediated Characterization of Full and Empty Adeno-Associated Virus Capsids
por: Coll De Peña, Adriana, et al.
Publicado: (2022)

Modifying immune responses to adeno-associated virus vectors by capsid engineering
por: Bentler, Martin, et al.
Publicado: (2023)

Innate and Adaptive Anti-SIV Responses in Macaque Semen: Implications for Infectivity and Risk of Transmission
por: Suphaphiphat, Karunasinee, et al.
Publicado: (2020)

Molecular Engineering of Adeno-Associated Virus Capsid Improves Its Therapeutic Gene Transfer in Murine Models of Hemophilia and Retinal Degeneration
por: Mary, Bertin, et al.
Publicado: (2019)

Adeno-associated viral capsid stability on anion exchange chromatography column and its impact on empty and full capsid separation
por: Khanal, Ohnmar, et al.
Publicado: (2023)

Human Immune Responses to Adeno-Associated Virus (AAV) Vectors
por: Ronzitti, Giuseppe, et al.
Publicado: (2020)

Comparison of analytical techniques to quantitate the capsid content of adeno-associated viral vectors
por: Werle, Amanda K., et al.
Publicado: (2021)

The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacs
por: Kashiwakura, Yuji, et al.
Publicado: (2022)

Antiretroviral Treatment Start-Time during Primary SIV(mac) Infection in Macaques Exerts a Different Impact on Early Viral Replication and Dissemination
por: Sellier, Pierre, et al.
Publicado: (2010)

Adeno-Associated Viral Vector-Mediated Transgene Expression Is Independent of DNA Methylation in Primate Liver and Skeletal Muscle
por: Léger, Adrien, et al.
Publicado: (2011)

Intra- and Inter-Subunit Disulfide Bond Formation Is Nonessential in Adeno-Associated Viral Capsids
por: Pulicherla, Nagesh, et al.
Publicado: (2012)

Capsid protein expression and adeno-associated virus like particles assembly in Saccharomyces cerevisiae
por: Backovic, Ana, et al.
Publicado: (2012)

Efficient Capsid Antigen Presentation From Adeno-Associated Virus Empty Virions In Vivo
por: Pei, Xiaolei, et al.
Publicado: (2018)

Structural characterization of a novel human adeno-associated virus capsid with neurotropic properties
por: Hsu, Hung-Lun, et al.
Publicado: (2020)

Chimeric Capsid Proteins Impact Transduction Efficiency of Haploid Adeno-Associated Virus Vectors
por: Chai, Zheng, et al.
Publicado: (2019)

Directed evolution of adeno-associated virus 5 capsid enables specific liver tropism
por: Wang, Yuqiu, et al.
Publicado: (2022)

Applying machine learning to predict viral assembly for adeno-associated virus capsid libraries
por: Marques, Andrew D., et al.
Publicado: (2020)

The tyrosine capsid mutations on retrograde adeno-associated virus accelerates gene transduction efficiency
por: Nakahama, Ryota, et al.
Publicado: (2022)

Biophysical characterization of adeno-associated virus capsid through the viral transduction life cycle
por: Xiang, Yanqiao Shawn, et al.
Publicado: (2023)

A Quantitative In Vitro Potency Assay for Adeno-Associated Virus Vectors Encoding for the UGT1A1 Transgene
por: Aronson, Sem J., et al.
Publicado: (2020)

Induction of tumor-specific CTL responses using the C-terminal fragment of Viral protein R as cell penetrating peptide
por: Gross, D. A., et al.
Publicado: (2019)

Optimization of the Capsid of Recombinant Adeno-Associated Virus 2 (AAV2) Vectors: The Final Threshold?
por: Aslanidi, George V., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2ds93qc86basfq50c7fard0umt